Novo Nordisk

272,25 DKK

+6,53%

1.024 følger denne virksomhed

NOVO B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Novo Nordisk

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Omsætning71.311,085.683,0290.403,078.087,076.857,074.976,079.144,0309.064,0
EBITDA35.972,041.935,0147.446,042.621,038.282,031.439,037.298,0149.640,0
EBIT33.822,036.737,0128.339,038.791,033.449,023.682,031.736,0127.658,0
EBIT-%47,4 %42,9 %44,2 %49,7 %43,5 %31,6 %40,1 %41,3 %
Overskud før skat34.384,035.557,0127.191,037.033,033.805,025.517,034.185,0130.540,0
Netto indkomst27.301,028.230,0100.988,029.034,026.503,020.006,026.891,0102.434,0